Bionik Laboratories Corp. Stock
Stocks
BNKL
US09074A2087
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -99.90% |
|
-.--% | - |
| 28/06/23 | Bionik Laboratories Corp. Announces Executive Changes | CI |
| 22/06/23 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| Market Cap | 12 10.54 9.84 9.03 16.91 1.15K 17.33 116.71 45.64 568.77 45.05 44.08 1.97K | P/E 2022 |
-0.21x | P/E 2023 | -0.56x |
|---|---|---|---|---|---|
| Enterprise Value | 1.98M 1.74M 1.63M 1.49M 2.8M 190M 2.87M 19.31M 7.55M 94.08M 7.45M 7.29M 325M | EV / Sales 2022 |
0.17x | EV / Sales 2023 | 2.65x |
| Free-Float |
100% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -99.90% |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0.5 | |
| 5 years | 0 | 2.9 | |
| 10 years | 0 | 222.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Russo
CEO | Chief Executive Officer | 46 | 14/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Michal Prywata
BRD | Director/Board Member | 35 | 18/03/2019 |
| Director/Board Member | 70 | 01/09/2017 | |
Richard Russo
BRD | Director/Board Member | 46 | 13/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/06/23 | Conversion | Chairman | 186,112 | 1.4416% | ||
| 13/06/23 | Conversion | Director | 3,102,878 | 24.0337% | ||
| 09/06/23 | Buy | Director | 180,555 | 1.3985% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -99.90% | -.--% | -.--% | -99.97% | 1.26K | ||
| +0.01% | +9.50% | +19.56% | +2.60% | 214B | ||
| -1.29% | +9.69% | -5.01% | -24.45% | 138B | ||
| -2.40% | +3.64% | -28.94% | +8.14% | 125B | ||
| -0.04% | +7.14% | -56.76% | -10.93% | 68.43B | ||
| +2.49% | +1.65% | +6.57% | +2.41% | 49.38B | ||
| +4.51% | +8.59% | -22.65% | -28.66% | 47.55B | ||
| -0.17% | +5.13% | +17.07% | +11.31% | 39.63B | ||
| -1.15% | +2.34% | +25.16% | +32.79% | 37.26B | ||
| +2.55% | +11.08% | -22.83% | -3.98% | 30.91B | ||
| Average | -9.98% | +5.80% | -6.78% | -11.07% | 75.03B | |
| Weighted average by Cap. | -0.43% | +7.26% | -5.12% | -3.00% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.27M 1.12M 1.04M 959K 1.79M 122M 1.84M 12.39M 4.84M 60.37M 4.78M 4.68M 209M | 1.81M 1.59M 1.48M 1.36M 2.54M 173M 2.61M 17.56M 6.87M 85.56M 6.78M 6.63M 296M |
| Net income | -10.41M -9.15M -8.54M -7.83M -14.67M -997M -15.03M -101M -39.59M -493M -39.08M -38.23M -1.71B | -4.95M -4.35M -4.06M -3.72M -6.97M -474M -7.14M -48.11M -18.81M -234M -18.57M -18.17M -810M |
| Net Debt | -1.99M -1.75M -1.63M -1.5M -2.81M -191M -2.88M -19.37M -7.57M -94.39M -7.48M -7.31M -326M | 1.98M 1.74M 1.63M 1.49M 2.8M 190M 2.87M 19.31M 7.55M 94.08M 7.45M 7.29M 325M |
Employees
12
- Stock Market
- Stocks
- BNKL Stock
Select your edition
All financial news and data tailored to specific country editions
















